Given the growing number of reports linking AXL expression to TKI resistance in human AML [25–27] and as GAB2 confers TKI resistance in CML [11] and AML cell lines [14], we analyzed the TKI sensitivity of AML BM depending on the Gab2 genotype. This evidence concerns the gene GAB2 and acute myeloid leukemia.